NNC0662-0419

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for NNC0662-0419, covering 2025-09-19 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity [Phase 2]

See pricing